Welcome to our dedicated page for iPath® B S&P 500® VIX Md-Trm Futs™ ETN SEC filings (Ticker: VXZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for the iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) focuses on regulatory documents associated with the iPath ETN platform issued by Barclays Bank PLC. Barclays states that each iPath ETN series is governed by a prospectus supplement and a pricing supplement that are filed with the U.S. Securities and Exchange Commission (SEC). These documents set out the detailed terms of each ETN, including index linkage, calculation mechanics, fees, and risk factors.
In its public announcements, Barclays repeatedly directs investors to the applicable prospectus supplement and pricing supplement and to the section titled “Risk Factors” or “Selected Risk Considerations” for a fuller description of the risks associated with its ETNs. The filings explain that iPath ETNs are unsecured debt obligations of Barclays Bank PLC, are not obligations of or guaranteed by any third party, and may result in investors losing some or all of their principal. They also discuss market and volatility risk, liquidity considerations, and the uncertainty surrounding tax treatment.
On Stock Titan, this page aggregates the available SEC filings related to VXZ and the broader iPath ETN program. Real-time updates from the SEC’s EDGAR system allow users to see when new prospectus supplements, pricing supplements, or other registration statements are filed for Barclays’ ETNs. AI-powered summaries help explain the key points of lengthy documents, such as how payment on an ETN is determined, what events can trigger redemption, and which risk factors Barclays emphasizes for that series.
Although no VXZ-specific SEC filings are listed in the materials provided here, the general framework described by Barclays applies to iPath ETNs as a group. Investors can use this page to review historical and newly filed documents for VXZ when they are available, and to understand how Barclays presents credit risk, market risk, and structural features of its ETNs in formal SEC filings.
Barclays Bank PLC has filed a pricing supplement for Trigger Autocallable Contingent Yield Notes linked to the S&P 500 and EURO STOXX 50 indices, due June 28, 2035. The notes offer:
- Quarterly contingent coupon payments at 7.15% per annum if both indices close at or above their coupon barriers (75% of initial levels)
- Automatic early redemption if both indices close at or above their initial levels on quarterly observation dates starting June 24, 2026
- Risk of principal loss if either index closes below its 75% downside threshold at maturity
Key features include a $10 per note offering price with minimum investment of $1,000, estimated value between $8.515-$9.315 per note. The notes carry significant risks including potential loss of principal, limited upside potential, and credit risk of Barclays Bank PLC. They are subject to U.K. Bail-in Power and are not listed on any securities exchange.
Barclays Bank PLC has filed a free writing prospectus for Contingent Income Callable Securities due July 2, 2030, linked to the performance of three major indices: MSCI EAFE Index, Russell 2000 Index, and S&P 500 Index.
Key features include:
- Quarterly contingent payments of at least $20.00 (2.00%) if all underliers are above 70% of initial value
- Early redemption option at issuer's discretion on any payment date
- Principal protection if no underlier falls below 60% of initial value at maturity
- Risk of significant loss if any underlier falls below threshold - investors could lose entire investment
The estimated value of securities ($882.70 to $962.70) is below issue price. Notable risks include exposure to worst-performing underlier, early redemption risk, and U.K. Bail-in Power acknowledgment. The securities will not be listed on any exchange, limiting secondary market trading opportunities.